Ascend Laboratories, LLC recalls Atorvastatin Calcium Tablets USP, 20 mg, Rx Only, a). 90-count(NDC 67877-512-90), b). 500-count (NDC 67877-512-05), c).…
- Recall date
- September 19, 2025
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0019-2026
- FDA classification
- Class II
- Brand / firm
- Ascend Laboratories, LLC
- Sold / distributed
- U.S. Nationwide
Why it was recalled
Failed Dissolution Specifications
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Atorvastatin Calcium Tablets USP, 20 mg, Rx Only, a). 90-count(NDC 67877-512-90), b). 500-count (NDC 67877-512-05), c). 1000-count(NDC 67877-512-10),Manufactured by: Alkem Laboratories, Ltd. India, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054.
Get recall alerts
Free email alert whenever Ascend Laboratories, LLC has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Ascend Laboratories, LLC